Subscribe to Newsletter

Content by Mark Hillen:

Business & Profession Other

Benchmarking Cone Dystrophy

| Mark Hillen

What does analysis of the last five years of the cone dystrophy literature tell us about the priorities of the field and the major contributors to it?

Business & Profession Refractive

The Last Disciple of Charlie Kelman

| Mark Hillen

Sitting Down With… Jorge Alió, Professor and Chair of Ophthalmology, Miguel Hernández University of Alicante, and founder of VISSUM Corporation.

Subspecialties Neuro-ophthalmology

Targeting Heritable Childhood Blindness

| Mark Hillen

Gene sequencing study identifies a gene mutation responsible for heritable cases of LCA and OMS for the first time

Business & Profession Professional Development

The Ophthalmologist Power List 2015

| Mark Hillen

Who are the top 40 under 40?

Subspecialties Retina

What Makes For a Poor Anti-VEGF Responder?

| Mark Hillen

Obstructive sleep apnea risk is associated with poor response to anti-VEGF agents

Subspecialties Basic & Translational Research

Cancer. Bad Habits or Bad Luck?

| Mark Hillen

Sensational headlines like “Most cancer is bad luck” aren’t helpful– so what’s the real story?

Subspecialties Retina

Benchmarking ROP

| Mark Hillen

What does analysis of the last five years of literature on retinopathy of prematurity tell us?

Business & Profession Professional Development

Carl Zeiss Meditec Invests in Oraya Therapeutics

| Mark Hillen

CZM invests an undisclosed amount in Oraya over a two-year period to facilitate Oraya’s growth strategy

Business & Profession Professional Development

Cops and Mobbers

| Mark Hillen

Could your career be a victim of mobbing?

Business & Profession Professional Development

Are Women Publishing More Now Than Ever?

| Mark Hillen

More women have been entering the profession for decades – but is that being reflected in the literature?

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: